Amicus Therapeutics (FOLD) Current Assets: 2009-2025
Historic Current Assets for Amicus Therapeutics (FOLD) over the last 16 years, with Sep 2025 value amounting to $594.1 million.
- Amicus Therapeutics' Current Assets rose 19.18% to $594.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $594.1 million, marking a year-over-year increase of 19.18%. This contributed to the annual value of $504.7 million for FY2024, which is 4.49% up from last year.
- As of Q3 2025, Amicus Therapeutics' Current Assets stood at $594.1 million, which was up 10.42% from $538.0 million recorded in Q2 2025.
- Amicus Therapeutics' Current Assets' 5-year high stood at $650.5 million during Q3 2021, with a 5-year trough of $399.7 million in Q1 2023.
- For the 3-year period, Amicus Therapeutics' Current Assets averaged around $483.4 million, with its median value being $483.1 million (2023).
- In the last 5 years, Amicus Therapeutics' Current Assets rose by 25.17% in 2021 and then declined by 29.51% in 2022.
- Amicus Therapeutics' Current Assets (Quarterly) stood at $596.8 million in 2021, then declined by 28.99% to $423.8 million in 2022, then increased by 13.98% to $483.1 million in 2023, then increased by 4.49% to $504.7 million in 2024, then grew by 19.18% to $594.1 million in 2025.
- Its Current Assets stands at $594.1 million for Q3 2025, versus $538.0 million for Q2 2025 and $510.8 million for Q1 2025.